W.G. Shaheen & Associates Dba Whitney & CO Amgen Inc Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$915 Million
Q3 2024

A detailed history of W.G. Shaheen & Associates Dba Whitney & CO transactions in Amgen Inc stock. As of the latest transaction made, W.G. Shaheen & Associates Dba Whitney & CO holds 9,130 shares of AMGN stock, worth $2.69 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

9,130

Previous 9,361 2.47%

Holding current value

$2.69 Million

Previous $2.92 Million 0.58%

% of portfolio

0.32%

Previous 0.34%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$309.38 - $337.38 $71,466 - $77,934	-231 Reduced 2.47%	9,130 $2.94 Million
Q2 2024 Jul 30, 2024	SELL	$262.75 - $319.31 $15,765 - $19,158	-60 Reduced 0.64%	9,361 $2.92 Million
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $134,435 - $162,280	-500 Reduced 5.04%	9,421 $2.68 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $18,154 - $20,480	71 Added 0.72%	9,921 $2.86 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $4,154 - $5,157	-19 Reduced 0.19%	9,850 $2.65 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $8,785 - $10,388	41 Added 0.42%	9,869 $2.19 Million
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $19,417 - $23,667	86 Added 0.88%	9,828 $2.38 Million
Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $4,809 - $6,111	-21 Reduced 0.22%	9,742 $2.56 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $2,244 - $2,531	-10 Reduced 0.1%	9,763 $2.2 Million
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $13,381 - $14,890	58 Added 0.6%	9,773 $2.38 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $5.59 Million - $6.18 Million	-25,490 Reduced 72.4%	9,715 $2.35 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $781,797 - $894,695	-3,931 Reduced 10.04%	35,205 $7.92 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $90,214 - $105,697	425 Added 1.1%	39,136 $8.32 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $25,693 - $28,505	110 Added 0.28%	38,711 $9.44 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $99,637 - $116,111	449 Added 1.18%	38,601 $9.6 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $76,165 - $90,699	352 Added 0.93%	38,152 $9.87 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $69,925 - $77,763	298 Added 0.79%	37,800 $9.61 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $1.77 Million - $2.18 Million	8,963 Added 31.41%	37,502 $8.85 Million
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $71,984 - $95,471	395 Added 1.4%	28,539 $5.79 Million
Q4 2019 Feb 06, 2020	BUY	$189.21 - $243.2 $10,974 - $14,105	58 Added 0.21%	28,144 $6.79 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $126,752 - $151,875	728 Added 2.66%	28,086 $6.02 Million
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $35,007 - $41,036	210 Added 0.77%	27,358 $5.04 Million
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $157,537 - $177,579	871 Added 3.31%	27,148 $4.87 Million
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $161,630 - $188,674	906 Added 3.57%	26,277 $4.89 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $125,811 - $141,836	679 Added 2.75%	25,371 $4.97 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $112,415 - $126,267	677 Added 2.82%	24,692 $4.56 Million
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $78,276 - $91,476	462 Added 1.96%	24,015 $4.09 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $167,946 - $187,647	995 Added 4.41%	23,553 $4.1 Million
Q2 2017 Aug 11, 2017	BUY	N/A	22,558	22,558 $3.89 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account

W.G. Shaheen & Associates Dba Whitney & CO Amgen Inc Transaction History